These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19890499)

  • 21. Moxifloxacin for tuberculosis.
    Singh KP; Brown M; Murphy ME; Gillespie SH
    Lancet Infect Dis; 2012 Mar; 12(3):176; author reply 177-8. PubMed ID: 22361420
    [No Abstract]   [Full Text] [Related]  

  • 22. [The achievements of the fundamental sciences and new approaches in the chemotherapy of tuberculosis].
    Egorov AM
    Probl Tuberk; 2000; (5):11-5. PubMed ID: 11077844
    [No Abstract]   [Full Text] [Related]  

  • 23. [Incidence of resistant mutants of Mycobacterium tuberculosis (MT) strains from different areas of Rumania. Bacteriological study--epidemiological aspects].
    Anastasatu C; Băicoianu S; Teodorescu A
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):212-22. PubMed ID: 4998673
    [No Abstract]   [Full Text] [Related]  

  • 24. [Principles of the antitubercular therapy].
    Bojalil LF
    Gac Med Mex; 1975 Jul; 110(1):63-6. PubMed ID: 807497
    [No Abstract]   [Full Text] [Related]  

  • 25. Toward a new therapy for tuberculosis.
    Rubin EJ
    N Engl J Med; 2005 Mar; 352(9):933-4. PubMed ID: 15745987
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental basis for the chemotherapy of tuberculosis.
    Grumbach F
    Antimicrob Agents Chemother (Bethesda); 1965; 5():1058-64. PubMed ID: 4956791
    [No Abstract]   [Full Text] [Related]  

  • 27. [New antitubercular drugs].
    Krasucka-Kluźniak A
    Pneumonol Pol; 1990; 58(4-5):163-6. PubMed ID: 2168041
    [No Abstract]   [Full Text] [Related]  

  • 28. New tuberculosis therapeutics: a growing pipeline.
    Spigelman MK
    J Infect Dis; 2007 Aug; 196 Suppl 1():S28-34. PubMed ID: 17624823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Welcome to 'Tuberculosis drug discovery and development'.
    D'Oca G
    Future Med Chem; 2010 Aug; 2(8):1241-2. PubMed ID: 21426014
    [No Abstract]   [Full Text] [Related]  

  • 30. [Primary resistance of Mycobacterium tuberculosis in Brazil].
    de Lima Filho MT; de Oliveira AG; Nishi I; Saraiva LG; de Melo FA
    AMB Rev Assoc Med Bras; 1980 Jun; 26(6):182-4. PubMed ID: 6781015
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro susceptibility of Mycobacterium bovis against moxifloxacin.
    Weiss T; Schönfeld N; Bettermann G; Blum TG; Kollmeier J; Mauch H; Bauer TT; Rüssmann H
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1562. PubMed ID: 23044455
    [No Abstract]   [Full Text] [Related]  

  • 32. [Resistance to antitubercular drugs in Chile].
    Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P
    Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug resistance of Mycobacterium (including clinical studies)].
    Fukuhara T
    Kekkaku; 1976 May; 51(5):158-60. PubMed ID: 819705
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on pyrazine derivatives. XXII. Synthesis and tuberculostatic activity of the products of reactions of pyrazinyl-1,3,4-oxadiazol-2-thione with amines].
    Pancechowska-Ksepko D; Foks H; Janowiec M; Zwolska-Kwiek Z
    Acta Pol Pharm; 1988; 45(3):193-200. PubMed ID: 3149138
    [No Abstract]   [Full Text] [Related]  

  • 36. [Resistance to antitubercular drugs in patients with tuberculosis registered in the antituberculosis clinics in Poland 1966-1980].
    Szczuka I
    Pneumonol Pol; 1982 Oct; 50(10):497-501. PubMed ID: 6820494
    [No Abstract]   [Full Text] [Related]  

  • 37. Quinoline alkaloids from Lunasia amara inhibit Mycobacterium tuberculosis H37Rv in vitro.
    Aguinaldo AM; Dalangin-Mallari VM; Macabeo AP; Byrne LT; Abe F; Yamauchi T; Franzblau SG
    Int J Antimicrob Agents; 2007 Jun; 29(6):744-6. PubMed ID: 17399957
    [No Abstract]   [Full Text] [Related]  

  • 38. A review on various heterocyclic moieties and their antitubercular activity.
    Sharma S; Sharma PK; Kumar N; Dudhe R
    Biomed Pharmacother; 2011 Jul; 65(4):244-51. PubMed ID: 21715130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug resistance among tuberculosis patients attending diagnostic and treatment centres in Makassar, Indonesia.
    Massi MN; Wahyuni S; Halik H; ; Yusuf I; Leong FJ; Dick T; Phyu S
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):489-95. PubMed ID: 21396208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoniazid activity is terminated by bacterial persistence.
    Mitchison DA; Jindani A; Davies GR; Sirgel F
    J Infect Dis; 2007 Jun; 195(12):1871-2; author reply 1872-3. PubMed ID: 17492605
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.